Retroviral vectors for delivery of interfering RNA

Details for Australian Patent Application No. 2004286231 (hide)

Owner Aventis Pharmaceuticals Inc

Inventors Kothari, Nayantara; Grueneberg, Dorre; Bain, Gerard

Agent Watermark

Pub. Number AU-B-2004286231

PCT Pub. Number WO2005/042754

Priority 60/513,313 22.10.03 US

Filing date 21 October 2004

Wipo publication date 12 May 2005

Acceptance publication date 10 September 2009

International Classifications

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

C12N 15/867 (2006.01) Mutation or genetic engineering - Retroviral vectors

Event Publications

18 May 2006 PCT application entered the National Phase

  PCT publication WO2005/042754 Priority application(s): WO2005/042754

10 September 2009 Application Accepted

  Published as AU-B-2004286231

14 January 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004286232-Compositions of stabilized DNA for coating microprojections

2004286229-Control rod mechanism and system